Tokyo, Japan

Shigeto Kawai

USPTO Granted Patents = 13 


 

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 80(Granted Patents)


Location History:

  • Gotemba, JP (2003)
  • Gotenba, JP (2010)
  • Kanagawa, JP (2011)
  • Shizuoka, JP (2012)
  • Kamakura, JP (2013)
  • Meguro-ku, JP (2017 - 2018)
  • Tokyo, JP (2014 - 2020)

Company Filing History:


Years Active: 2003-2020

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Shigeto Kawai: Innovator in Cancer Diagnosis and Treatment

Introduction

Shigeto Kawai is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research, holding a total of 13 patents. His work focuses on innovative methods for diagnosing and treating various types of cancer.

Latest Patents

Kawai's latest patents include groundbreaking methods for the diagnosis and treatment of cancer using anti-desmoglein-3 antibodies. These methods involve the detection of a DSG3 protein, which has been found to be expressed at very high frequencies in lung cancer at both the gene and protein levels. The invention details how to utilize antibodies that recognize DSG3 proteins, along with pharmaceutical compositions, cell growth inhibitors, and anticancer agents containing DSG3-binding antibodies as active ingredients. Additionally, Kawai has developed methods for inducing cell damage in DSG3-expressing cells and suppressing their proliferation through the use of DSG3-binding antibodies. Another significant patent involves the use of an anti-ITM2A antibody, which binds to the ITM2A protein. This antibody is instrumental in diagnosing, preventing, and treating various cancers, including Ewing's sarcoma and multiple myeloma. The invention also encompasses pharmaceutical compositions and methods for predicting treatment efficacy and determining the presence of cancer in test subjects.

Career Highlights

Throughout his career, Shigeto Kawai has worked with notable organizations, including Chugai Pharmaceutical Co., Ltd. and The University of Tokyo. His research has significantly advanced the understanding of cancer biology and therapeutic approaches.

Collaborations

Kawai has collaborated with esteemed colleagues such as Hiroyuki Aburatani and Kiyotaka Nakano, contributing to the collective effort in cancer research and innovation.

Conclusion

Shigeto Kawai's contributions to cancer diagnosis and treatment through his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cancer therapies and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…